CELLMED 2021 KCI Impact Factor : 0.02

Korean | English

eISSN : 2233-8985

http://journal.kci.go.kr/cellmed
Aims & Scope
moremore
AIMS AND SCOPE   Cellmed Orthocellular Medicine Pharmaceutical Association (COMPA) aims for the development of medicine combined with Humanities through human agony, rich experience and wisdom about medicine based on spirit of humanity. COMPA plays an active role in promoting the exchange of academic achievements of worldwide scholars who are interested in this field for the purpose of developing humanitas medicine by submitting their achievements through our international journal, a CELLMED. The CELLMED journal publishes findings of significance in all areas of medicine including medical classics, medical history, clinical medicine, herbology, prescriptionology, pharmacology, physiology, pathology, preventive medicine, nutrition, acupuncture, moxibustion, and interdisciplinary areas. The journal also welcomes studies that involve models relevant to medical theory and describing molecular mechanisms. Manuscripts from any other related fields of studies that can significantly contribute to the development of humanitas medicine are welcomed as review articles.   --------------------------------------------------------------------------------------------------- Notice Original article should include the findings of significance in all areas of medicine ---------------------------------------------------------------------------------------------------- CELLMED journal is published quarterly on the last days of February, May, August, and November by Cellmed Orthocellular Medicine and Pharmaceutical Association (COMPA). CELLMED journal is an online-only, peer-reviewed, open access journal.     compa-editorialteam@compa.co.kr  
Editor-in-Chief
moremore
Hyung-Min Kim

(Kyung Hee University)

Citation Index
moremore
  • KCI IF(2yr) : 0.02
  • KCI IF(5yr) : 0.02
  • Centrality Index(3yr) : 0.186
  • Immediacy Index : 0.0

Current Issue : 2023, Vol.13, No.5

moremore
  • A Case Study on Hypertensive Patients Receiving Ortho-Cellular Nutrition Therapy (OCNT)

    Ok-hee Lee | 2023, 13(5) | pp.17~17 | number of Cited : 0
    Abstract PDF
    Objective: A case report on the improvement of hypertension patients by Ortho-Cellular Nutrition Therapy (OCNT). Methods: A 59-year-old Korean male with hypertension having bad habits as alcohol, smoking and overweight. Results: Weight loss and blood pressure improved after Ortho-Cellular Nutrition Therapy (OCNT). Conclusion: Ortho-Cellular Nutrition Therapy (OCNT) is effective in relieving the symptoms of patients with chronic symptoms to hypertension.
  • A Case Study on Patients with Acanthosis Nigricans Receiving Ortho-Cellular Nutrition Therapy (OCNT)

    Sook-hyun Kim | 2023, 13(5) | pp.18~18 | number of Cited : 0
    Abstract PDF
    Objective: A case report on the improvement of patients with acanthosis nigricans by Ortho-Cellular Nutrition Therapy (OCNT). Methods: A 23-year-old Korean male who has begun to have the symptoms of acanthosis nigricans two years ago has been experiencing more severe symptoms in the past year. Results: Skin pigmentation and lichenification symptoms improved after Ortho-Cellular Nutrition Therapy (OCNT). Conclusion: Ortho-Cellular Nutrition Therapy (OCNT) is effective in relieving the symptoms of patients with acanthosis nigricans.
  • A Case Study on the Improvement of Hair Loss Using Ortho-Cellular Nutrition Therapy (OCNT)

    Ki-won Kim | 2023, 13(5) | pp.19~19 | number of Cited : 0
    Abstract PDF
    Objective: A case report on the improvement of bald crown by Ortho-Cellular Nutrition Therapy (OCNT). Methods: A 61-year-old Korean male suffering from bald crown, male pattern baldness, and reduced hair thicknessResults: Bald crown improved after Ortho-Cellular Nutrition Therapy (OCNT). Conclusion: Ortho-Cellular Nutrition Therapy (OCNT) is effective in relieving the symptoms of hair loss patients.
  • LOADING
  • LOADING